Latest Hematology Stories

Inflammatory response to bioactive components of blood Results of new research from the University of Adelaide are a promising step forward in helping to improve the quality of life-saving blood transfusions for preterm babies, by reducing the likelihood of adverse inflammatory responses to the blood. Blood transfusions are among the most common medical procedures experienced by preterm babies, who are often anemic and suffer blood loss. Researchers from the University of Adelaide's...

New insights into what causes uncontrollable bleeding in hemophilia patients are provided in a study published by Cell Press on November 20th in the Biophysical Journal. By revealing that blood clots spread in traveling waves through vessels, the study offers new strategies that could lead to the development of more effective treatments for hemophilia as well as common cardiovascular disorders. "Disorders of blood coagulation are a leading and immediate cause of mortality and morbidity in...

DALLAS, November 20, 2012 /PRNewswire/ -- - RnRMarketResearch.com adds new market research reports "Antithrombotic / Anticoagulant Drugs: Technologies and Global Markets" to its store. This report provides an overview of the global market for antithrombotic/anticoagulant drugs, which is changing due to factors such as an aging population, an increase in thrombotic events, and recent advances in pharmaceuticals. Analyses of global market trends, with data from 2011,...

For years, researchers have known that antiphospholipid antibodies (aPLs) can cause pregnancy loss and clotting, but they haven't known the true scope of the problem. Now a new study provides the first estimates of the prevalence of these antibodies in patients suffering from pregnancy loss, stroke, myocardial infarction, and deep vein thrombosis. "Based on the available data, our best estimate is that around 10 to 15% of clotting disorders are associated with autoimmune antiphospholipid...

STOCKHOLM, Sweden, November 12, 2012 /PRNewswire/ -- Pharmalink AB, a Swedish specialty pharma company, today announces it has entered into a service contract with GP Pharm for the manufacturing of Pharmalink's Busulipo(TM), which is under development to provide a best-in-class conditioning agent for use prior to hematopoietic stem cell transplantation (HSCT), often known as bone marrow transplantation. GP Pharm is a Spanish biopharmaceutical company that focuses on injectable...

LOS ANGELES, Nov. 7, 2012 /PRNewswire/ -- Twelve-month data from the Global Anticoagulant Registry in the FIELD (GARFIELD) show that poor management of stroke prevention therapy is widespread in everyday clinical practice, which may lead to elevated rates of mortality, stroke and bleeding among individuals with newly diagnosed with atrial fibrillation (AF). Data from the GARFIELD Registry describes AF management and outcomes in everyday clinical practice, highlighting unmet...

Blood Supply is Down 6,000+ Units From Hurricane Disruptions Despite Heroic Efforts of Many Regular Donors NEW YORK, Nov. 5, 2012 /PRNewswire-USNewswire/ -- New York Blood Center (NYBC), serving more than 20 million people in New York City, Long Island, the Hudson Valley, and New Jersey, is asking for post-hurricane emergency blood donations. Though hospital needs were met, and heroic donors found the NYBC facilities that were able to remain open, the unprecedented disruption...

RARITAN, N.J., Nov. 2, 2012 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. (Janssen) today announced the U.S. Food and Drug Administration (FDA) has approved XARELTO(®) (rivaroxaban), an oral anticoagulant, for the treatment of deep vein thrombosis (DVT) and/or pulmonary embolism (PE), and to reduce the risk of recurrence of DVT and PE following initial treatment. To view the multimedia assets associated with this release, please click:...

Future Appointments Are Encouraged to Maintain Supply; Type O-Negative Donors Especially Sought ST. PAUL, Minn., Oct. 30, 2012 /PRNewswire-USNewswire/ -- Memorial Blood Centers, among Minnesota's oldest and largest nonprofit community blood centers, is carefully monitoring the impact of Hurricane Sandy on regional and national blood supplies and is prepared to help blood centers on the East Coast in the aftermath of Hurricane Sandy. The blood inventory levels at Memorial Blood...

NEW YORK, Oct. 26, 2012 /PRNewswire/ -- The New York Blood Center (NYBC) is working with area hospitals to make sure there is no disruption in the critical blood and blood product supply if a major storm hits the Metropolitan Area next week. NYBC is calling upon donors who have made an appointment to give blood to keep the appointment. Donors without an appointment also can give blood in advance of the storm to assure an adequate supply next week. Information on donor centers and...